Research graph
References from Mathematical modeling of regulatory networks of intracellular processes – Aims and selected methods. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
10.1016/j.semcdb.2010.08.007
10.1016/j.semcdb.2010.08.007 · External reference
Quantitative studies for cell-division cycle control
10.3389/fphys.2019.01022 · 2019 · External reference
10.1109/jproc.2021.3129527
10.1109/jproc.2021.3129527 · External reference
Dual-controlled optogenetic system for the rapid down-regulation of protein levels in mammalian cells
10.1038/s41598-018-32929-7 · 2018 · External reference
Multiscale design of cell-type-specific pharmacokinetic/pharmacodynamic models for personalized medicine: application to temozolomide in brain tumors
10.1038/psp.2014.9 · 2014 · External reference
Computational oncology - mathematical modelling of drug regimens for precision medicine
10.1038/nrclinonc.2015.204 · 2015 · External reference
Physiologically based pharmacokinetic (PBPK) modeling in children
10.1038/clpt.2012.64 · 2012 · External reference
10.1016/j.bmcl.2019.06.007
10.1016/j.bmcl.2019.06.007 · External reference
Synthetic design and biological evaluation of new p53-MDM2 interaction inhibitors based on imidazoline core
2022 · External reference
10.1093/nar/gkab778
10.1093/nar/gkab778 · External reference
10.1083/jcb.200404158
10.1083/jcb.200404158 · External reference
Synthetic biology makes polymer materials count
10.1002/adma.201800472 · 2018 · External reference
10.4161/jkst.28087
10.4161/jkst.28087 · External reference
KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis
2021 · External reference
10.1016/j.csbj.2022.10.003
10.1016/j.csbj.2022.10.003 · External reference
The acute chest syndrome in sickle cell disease: Incidence and risk factors. The cooperative study of sickle cell disease
10.1182/blood.v84.2.643.643 · 1994 · External reference
10.1016/j.neo.2022.01.001
10.1016/j.neo.2022.01.001 · External reference
Petri net modelling of biological networks
10.1093/bib/bbm029 · 2007 · External reference
Qualitative modeling, analysis and control of synthetic regulatory circuits
10.1007/978-1-0716-1032-9_1 · 2021 · External reference
10.1016/j.csbj.2021.08.026
10.1016/j.csbj.2021.08.026 · External reference
A compact synthetic pathway rewires cancer signaling to therapeutic effector release
10.1126/science.aat6982 · 2019 · External reference
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
10.1200/jco.2003.09.081 · 2003 · External reference
10.1007/s10637-016-0399-7
10.1007/s10637-016-0399-7 · External reference
Physiologically based pharmacokinetics model in pregnancy: a regulatory perspective on model evaluation
10.3389/fped.2021.687978 · 2021 · External reference
Pharmacokinetic–pharmacodynamic modelling: history and perspectives
2006 · External reference
10.1093/nar/gkab1049
10.1093/nar/gkab1049 · External reference
Artificial gene regulatory networks-a review
10.1162/artl_a_00267 · 2018 · External reference
10.1128/jvi.01341-22
10.1128/jvi.01341-22 · External reference
10.1111/1751-7915.13937
10.1111/1751-7915.13937 · External reference
Computational methods for gene regulatory networks reconstruction and analysis: a review
10.1016/j.artmed.2018.10.006 · 2019 · External reference
Phase 1 dose escalation study of seribantumab (MM-121), an anti-HER3 monoclonal antibody, in patients with advanced solid tumors
10.1007/s10637-021-01145-y · 2021 · External reference
GeRNet: a gene regulatory network tool
10.1016/j.biosystems.2017.08.006 · 2017 · External reference
Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms
10.1002/bdd.2257 · 2021 · External reference
From discrete to continuous modeling of Lymphocyte development and plasticity in chronic diseases
10.3389/fimmu.2019.01927 · 2019 · External reference
Pulmonary drug absorption and systemic exposure in human: predictions using physiologically based biopharmaceutics modeling
10.1016/j.ejpb.2020.09.004 · 2020 · External reference
Global optimization of the Michaelis–Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats
10.1080/08958378.2020.1742818 · 2020 · External reference
Polygenic adaptation: integrating population genetics and gene regulatory networks
10.1016/j.tig.2021.03.005 · 2021 · External reference
Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data
2018 · External reference
Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes
10.1091/mbc.e12-10-0737 · 2013 · External reference
Optimal design of single-cell experiments within temporally fluctuating environments
2020 · External reference
10.1007/978-3-642-03223-3_4
10.1007/978-3-642-03223-3_4 · External reference
Discovering time-lagged rules from microarray data using gene profile classifiers
10.1186/1471-2105-12-123 · 2011 · External reference
Multi-parameter exploration of dynamics of regulatory networks
10.1016/j.biosystems.2020.104113 · 2020 · External reference
10.3390/cells8030280
10.3390/cells8030280 · External reference
Physiologically‐based pharmacokinetic modelling of a CYP2C19 substrate, BMS‐823778, utilizing pharmacogenetic data
10.1111/bcp.13565 · 2018 · External reference
Study of the bioenergetics to identify the novel pathways as a drug target against Mycobacterium tuberculosis using Petri net
10.1016/j.biosystems.2021.104509 · 2021 · External reference
Petri nets and ODEs as complementary methods for comprehensive analysis on an example of the ATM-p53-NF-kappa B signaling pathways
10.1038/s41598-022-04849-0 · 2022 · External reference
10.1016/j.jmb.2016.07.009
10.1016/j.jmb.2016.07.009 · External reference
Dynamic modeling of transcriptional gene regulatory networks
10.1007/978-1-0716-1534-8_5 · 2021 · External reference
10.1073/pnas.1803723115
10.1073/pnas.1803723115 · External reference
Unresolved reference
External reference
Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients
10.1007/s10549-016-3760-9 · 2016 · External reference
Application of open-source PBPK models in rat-to-human pharmacokinetic extrapolation of oral nicotine exposure
10.1016/j.comtox.2021.100182 · 2021 · External reference
Unresolved reference
External reference
Abstract P3-11-03: a randomized, phase 2 trial of preoperative MM-121 with paclitaxel in triple negative (TN) and hormone receptor (HR) positive, HER2-negative breast cancer
10.1158/1538-7445.sabcs14-p3-11-03 · 2015 · External reference
10.3390/pathogens7010024
10.3390/pathogens7010024 · External reference
10.3390/mps2020039
10.3390/mps2020039 · External reference
Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation
10.3389/fimmu.2022.947213 · 2022 · External reference
KEGG: new perspectives on genomes, pathways, diseases and drugs
10.1093/nar/gkw1092 · 2017 · External reference
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions
10.1093/nar/gkx1141 · 2018 · External reference
10.3390/ijms23126604
10.3390/ijms23126604 · External reference
10.1371/journal.pcbi.1006130
10.1371/journal.pcbi.1006130 · External reference
10.3390/ijms20205179
10.3390/ijms20205179 · External reference
Models for cell-free synthetic biology: make prototyping easier, better, and faster
10.3389/fbioe.2018.00182 · 2018 · External reference
Integrating cellular metabolism into a multiscale whole-body model
10.1371/journal.pcbi.1002750 · 2012 · External reference
Applied concepts in PBPK modeling: how to build a PBPK/PD model
10.1002/psp4.12134 · 2016 · External reference
Modeling regulatory networks using machine learning for systems metabolic engineering
10.1016/j.copbio.2020.02.014 · 2020 · External reference
On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth
10.3934/mbe.2013.10.787 · 2013 · External reference
On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
10.3934/mbe.2013.10.803 · 2013 · External reference
High-speed parameter search of dynamic biological pathways from time-course transcriptomic profiles using high-level Petri net
10.1016/j.biosystems.2020.104332 · 2021 · External reference
Prediction of drug disposition in diabetic patients by means of a physiologically based pharmacokinetic model
10.1007/s40262-014-0192-8 · 2015 · External reference
On global identifiability for arbitrary model parametrizations
10.1016/0005-1098(94)90029-9 · 1994 · External reference
10.1021/jp403156m
10.1021/jp403156m · External reference
Intergroupe Français des Leucémies Myéloïdes Chroniques. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
10.1016/s1470-2045(10)70233-3 · 2010 · External reference
10.1371/journal.pcbi.1010623
10.1371/journal.pcbi.1010623 · External reference
Extracellular optogenetics at the interface of synthetic biology and materials science
10.3389/fbioe.2022.903982 · 2022 · External reference
Computational design tools for synthetic biology
10.1016/j.copbio.2009.08.007 · 2009 · External reference
Multiscale modeling of cross-regulatory transcript and protein influences
10.1007/978-1-0716-1534-8_7 · 2021 · External reference
Enhanced production of heterologous proteins by a synthetic microbial community: conditions and trade-offs
10.1371/journal.pcbi.1007795 · 2020 · External reference
10.1142/s0219720016500268
10.1142/s0219720016500268 · External reference
Multiscale modeling of mucosal immune responses
2015 · External reference
Application of bioinformatics analysis to identify important pathways and hub genes in ovarian cancer affected by WT1
10.3389/fbioe.2021.741051 · 2021 · External reference
10.1093/nar/gkaa1106
10.1093/nar/gkaa1106 · External reference
10.1093/bioinformatics/btq562
10.1093/bioinformatics/btq562 · External reference
Modeling cell-free protein synthesis systems-approaches and applications
10.3389/fbioe.2020.584178 · 2020 · External reference
10.1002/cncr.31357
10.1002/cncr.31357 · External reference
10.1016/j.cell.2016.03.025
10.1016/j.cell.2016.03.025 · External reference
Heat shock response regulates stimulus-specificity and sensitivity of the pro-inflammatory NF-κB signalling
10.1186/s12964-020-00583-0 · 2020 · External reference
Inferring gene regulatory networks from multiple datasets
10.1007/978-1-4939-8882-2_11 · 2019 · External reference
10.1007/978-3-030-95860-2_8
10.1007/978-3-030-95860-2_8 · External reference
10.1016/j.csbj.2016.05.005
10.1016/j.csbj.2016.05.005 · External reference
10.1016/j.csbj.2020.09.025
10.1016/j.csbj.2020.09.025 · External reference
10.1056/nejm199406093302303
10.1056/nejm199406093302303 · External reference
Regulation of p53 by siRNA in radiation treated cells: simulation studies
10.2478/v10006-012-0075-9 · 2012 · External reference
10.1017/cbo9780511625268
10.1017/cbo9780511625268 · External reference
10.1016/j.jtbi.2018.11.028
10.1016/j.jtbi.2018.11.028 · External reference
10.1182/blood-2013-02-483750
10.1182/blood-2013-02-483750 · External reference
10.1038/nrd.2016.246
10.1038/nrd.2016.246 · External reference
10.1016/j.csbj.2021.08.028 · Admitted local publication
Epirubicin/docetaxel regimen in progressive breast cancer-a phase II study
10.1097/00001813-200210000-00004 · 2002 · External reference
10.1016/j.mib.2020.02.008
10.1016/j.mib.2020.02.008 · External reference
A web tool for consensus gene regulatory network construction
10.3389/fgene.2021.745827 · 2021 · External reference
10.1073/pnas.1913773116
10.1073/pnas.1913773116 · External reference
Applications of global sensitivity analysis to the optimization of a dermal PBPK model of Bromochloromethane
2021 · External reference
Quantitative characterization of genetic parts and circuits for plant synthetic biology
10.1038/nmeth.3659 · 2016 · External reference
To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia
10.3324/haematol.2018.201897 · 2018 · External reference
10.1126/scisignal.2000352
10.1126/scisignal.2000352 · External reference
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)
10.1038/npjsba.2016.34 · 2017 · External reference
10.1016/j.csbj.2020.03.001
10.1016/j.csbj.2020.03.001 · External reference
Network-based drug repurposing: a critical review
10.2174/2589977514666220214120403 · 2022 · External reference
Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective
10.1002/cpt.1013 · 2018 · External reference
A cell-level systems PK-PD model to characterize in vivo efficacy of ADCs
2019 · External reference
Unresolved reference
2009 · External reference
Coupled analytical and numerical approach to uncovering new regulatory mechanisms of intracellular processes
10.2478/v10006-010-0060-0 · 2010 · External reference
Model-based analysis of interferon-beta induced signaling pathway
10.1093/bioinformatics/btn400 · 2008 · External reference
Structure identifiability in metabolic pathways: parameter estimation in models based on the power-law formalism
10.1042/bj2980303 · 1994 · External reference
10.1007/978-3-319-28095-0
10.1007/978-3-319-28095-0 · External reference
dbPepNeo: a manually curated database for human tumor neoantigen peptides
2020 · External reference
10.1093/nar/gkx247
10.1093/nar/gkx247 · External reference
10.1002/pro.3307
10.1002/pro.3307 · External reference
Autophagy regulatory network—a systems-level bioinformatics resource for studying the mechanism and regulation of autophagy
10.4161/15548627.2014.994346 · 2015 · External reference
10.1016/j.tcb.2020.04.002
10.1016/j.tcb.2020.04.002 · External reference
10.1016/j.jtbi.2018.11.034
10.1016/j.jtbi.2018.11.034 · External reference
A review of mathematical and computational methods in cancer dynamics
10.3389/fonc.2022.850731 · 2022 · External reference
10.1126/science.1092472
10.1126/science.1092472 · External reference
10.1007/10_2020_158
10.1007/10_2020_158 · External reference
Characterization of the synthetic biology-inspired implementation of a materials-based positive feedback loop
10.1016/j.dib.2018.05.074 · 2018 · External reference
10.1016/j.csbj.2020.10.022 · Admitted local publication
10.1016/j.jtbi.2022.111055
10.1016/j.jtbi.2022.111055 · External reference
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
2010 · External reference
10.1038/35066048
10.1038/35066048 · External reference
PK-Sim®: a physiologically based pharmacokinetic ‘whole-body’ model
10.1016/s1478-5382(03)02342-4 · 2003 · External reference
10.1038/s41576-021-00389-x
10.1038/s41576-021-00389-x · External reference
A mechanistic model predicting hematopoiesis and tumour growth to optimize docetaxel+epirubicin (ET) administration in metastatic breast cancer (MBC): phase I trial
2007 · External reference
10.1124/pr.120.019554
10.1124/pr.120.019554 · External reference
A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer
10.1016/j.csbj.2022.11.037 · 2022 · External reference
GeNeCK: a web server for gene network construction and visualization
10.1186/s12859-018-2560-0 · 2019 · External reference
A comprehensive overview and critical evaluation of gene regulatory network inference technologies
10.1093/bib/bbab009 · 2021 · External reference
10.1093/nar/gkz240
10.1093/nar/gkz240 · External reference
Metascape provides a biologist-oriented re-631 source for the analysis of systems-level datasets
2019 · External reference
PBPK modeling and simulation in drug research and development
10.1016/j.apsb.2016.04.004 · 2016 · External reference
10.1016/j.csbj.2018.06.002
10.1016/j.csbj.2018.06.002 · External reference
